Navigation Links
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Date:11/26/2007

nt boys and girls who are at least one year post-menarche, 10-17 years of age, with heFH if after an adequate trial of diet therapy the following findings are present:

1. LDL-C remains >189 mg/dL or

2. LDL-C remains >160 mg/dL and:

-- there is a positive family history of premature cardiovascular

disease or

-- two or more other CVD risk factors are present in the adolescent

patient

General Recommendations

Prior to initiating therapy with lovastatin, secondary causes for hypercholesterolemia (e.g., poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be excluded, and a lipid profile performed to measure total-C, HDL-C, and TG. For patients with TG less than 400 mg/dL (<4.5 mmol/L), LDL-C can be estimated using the following equation:

LDL-C = total-C - [0.2 x (TG) + HDL-C]

For TG levels >400 mg/dL (>4.5 mmol/L), this equation is less accurate and LDL-C concentrations should be determined by ultracentrifugation. In hypertriglyceridemic patients, LDL-C may be low or normal despite elevated total-C. In such cases, MEVACOR is not indicated.

The National Cholesterol Education Program (NCEP) Treatment Guidelines are summarized below:

NCEP Treatment Guidelines:

LDL-C Goals and Cutpoints for Therapeutic Lifestyle Changes

and Drug Therapy in Different Risk Categories

LDL Level at Which

LDL Goal to Initiate LDL Level at Which

Risk Category (mg/dL) Therapeutic to Consider Drug

Lifestyle Changes Therapy

(mg/dL) (mg/dL)

CHD+ or CHD risk <100 Greater Than or Equal Greater Than or Equal

equivalents
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 “ Nursing Homes are starting ... reads the title of a recent April 2015 New York ... loved ones to the hospital, 20-plus years of research have ... shows that high-quality nursing homes are both safer for older ... quality of nursing homes varying widely, patients and family members ...
(Date:5/27/2015)... May 27, 2015 While hair transplantation ... loss, a new pilot study conducted by a physician ... (ISHRS) has found hair follicle grafting can help treat ... was partially funded by ISHRS, which offers research grants ... hair restoration. , In the past decade, numerous ...
(Date:5/27/2015)... TX (PRWEB) May 27, 2015 The ... information. Topics include: Why investors should consider oil and ... how and why wells are drilled, industry news, IRA ... Carson Energy's 32 years of knowledge and experience is ... gas investment community to be able to access 24 ...
(Date:5/27/2015)... NJ (PRWEB) May 27, 2015 ... Network (BCAN) , whose mission is to advance research, ... cancer, have joined forces to battle the fifth most ... in the bladder’s lining start to grow out of ... and their families at every stage of the cancer ...
(Date:5/27/2015)... Difass USA, a modern supplement brand committed ... first three flagship products, Dormiva™, Relaxiva™ and Reminiva™. All ... http://www.difassusa.com . , A restful night’s sleep is ... people struggle with getting the full amount of sleep ... designed to help you fall asleep and stay asleep, ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2
... (Amex: HH ) today announced the appointment ... Counsel and Corporate Secretary. He has also been ... has over 23 years of corporate legal experience in ... consumer and other class actions, as well as labor, ...
... Jan. 27 Mercury Computer Systems, Inc. (NASDAQ: ... computing systems and software for complex image, sensor, and ... agreement and closed on the sale of its wholly-owned ... GmbH, to Australia-based Pro Medicus Limited. The financial terms ...
... researchers say , , TUESDAY, Jan. 27 (HealthDay News) -- ... potential new method of promoting recovery from chronic stress ... "fight or flight" response. , The approach focuses on ... body,s major control systems. The HPA axis uses hormone ...
... following was released today by the Healthcare Information and ... and Management Systems Society (HIMSS) will join the U.S. ... a press conference to call attention to the widespread ... Recovery and Reinvestment Plan of 2009 currently pending in ...
... FLA) Leading medical experts at the Center for ... School of Medicine (BUSM) reported today that nine-year NFL ... from chronic traumatic encephalopathy (CTE), a degenerative brain disease ... at the age of 45. In addition, the CSTE ...
... ValueOptions(R), Inc., the nation,s largest independent ... North Carolina Employer Solutions Service Center received a ... Quality Assurance (NCQA), an independent, not-for-profit organization dedicated ... managed care plans, managed behavioral health care organizations ...
Cached Medicine News:Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 2Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 3Health News:Mercury Computer Systems Announces the Sale of Visage Imaging to Pro Medicus Limited 2Health News:Mercury Computer Systems Announces the Sale of Visage Imaging to Pro Medicus Limited 3Health News:Mercury Computer Systems Announces the Sale of Visage Imaging to Pro Medicus Limited 4Health News:Center for the Study of Traumatic Encephalopathy announces new findings 2Health News:Center for the Study of Traumatic Encephalopathy announces new findings 3Health News:Center for the Study of Traumatic Encephalopathy announces new findings 4Health News:Center for the Study of Traumatic Encephalopathy announces new findings 5Health News:NCQA Awards Accredited Status to ValueOptions(R) North Carolina Employer Solutions Service Center 2Health News:NCQA Awards Accredited Status to ValueOptions(R) North Carolina Employer Solutions Service Center 3
(Date:5/27/2015)... NEW YORK , May 27, 2015  Precision ... announced the findings from its 2015 Digital Trends Study ... decision makers are aware of the concepts of big ... fully implement them.  The Health Information ... incentives for healthcare providers to make use of electronic ...
(Date:5/27/2015)... , May 27, 2015 ... addition of the  "North America Portable X Ray ... - 2019)"  report to their offering.  ... North America market for Portable X-Ray ... CAGR from 2014 to 2020 X-Ray ...
(Date:5/27/2015)... , May 27, 2015  With all the ... the services they provide to keep patients healthy should ... ripple effect of the Affordable Care Act continues to ... insurance payer partners, making it more important than ever ... communication with those they contract with for patient care. ...
Breaking Medicine Technology:Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3North America Portable X Ray Devices Market Report 2015 - Growth, Trends And Forecasts 2014-2019 2Physicians Seek Payer Inclusion, Not Impediment 2Physicians Seek Payer Inclusion, Not Impediment 3
... Boehringer Ingelheim and Eli Lilly and Company ... positive opinion from the European Medicines Agency,s (EMA) medicinal ... (to be marketed under the trade name Trajenta® in ... diabetes. If adopted by the European Commission, linagliptin will ...
... Md., June 24, 2011 Breast cancer patients and their ... am outside of the Federal Drug Administration (FDA).  At issue ... drug Avastin from the approved medication list for treatment of ... 2008 for use to treat breast cancer. Terry ...
Cached Medicine Technology:Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 2Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 3Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 4Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 5Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 6Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 7Breast Cancer Patients and Families Stand Up To FDA 2
... 10% Povidone Iodine USP, 1% available Iodine, ... prep, Povidone Iodine Gel helps to minimize ... patient, thus reducing the chance of patient ... a one step gel for venipuncture site ...
... is a viscous antimicrobial that contains 10% ... broad-spectrum germicidal action. As a preoperative patient ... the pooling of prepping solutions under the ... burns. Povidone Iodine Topical Gel is film ...
... is appropriate for pre-surgical patient preparation ... spray); disinfecting of wounds and burns; ... and abrasions. It also acts as ... and office procedures, providing protection against ...
Idophor PVP Scrub Winged Sponges...
Medicine Products: